After a heavy beating in 2019, when cannabis firms’ shares fell 80% from their peak valuation to less than $2.80 at year-end, Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) stock price hasn’t performed any better so far in 2020. Some investors may wish they had invested in an embattled CannTrust Holdings (TSX:TRST)(NYSE:CTST) in January this year instead. During the first 20 days of 2020,…
Read MoreTag: canntrust
Aurora (TSX:ACB) Stock Has a Measly $1.30 Price Target for 2020
It is no secret that 2019 was a horrible year for investors who put their faith in the legal marijuana industry. Cannabis stocks were decimated last year with massive sell-offs after disappointing performances across the board. Shares of the cannabis giant Aurora Cannabis (TSX:ACB)(NYSE:ACB) have declined by more than 83% since March 2019. Cannabis producers in Canada are struggling with…
Read MoreWhy Aurora Cannabis’ (TSX:ACB) Stock Price Could Double in 2020
The last year was nothing short of catastrophic for the Cannabis industry. In a year that saw the S&P/TSX Composite Index post its best year since 2009, the Canadian Marijuana Index had its worst year on record. In 2019, the Canadian Marijuana Index lost approximately 55% of its value. After a couple of bullish years — 2016 and 2017 —…
Read MoreCould CannTrust Holdings (TSX:TRST) Stock Recover in 2020?
A beleaguered CannTrust Holdings’s (TSX:TRST)(NYSE:CTST) stock remains heavily beaten down today, even as the company appears much closer to regaining its licences and has preserved cash flow during the period with suspended operating licences. Shares traded around $1.20 exit 2019, and they had recorded an agonizing low of $0.99 a share recently — a price point too bearish, even after…
Read MoreMy Worst Investment Decision in 2019
Disbelief, outright denial, and a fear of booking losses too early can be costly mental biases as far as investment decision making is concerned, and resultant capital losses may prove more permanent than we desire. These mental states may have significantly influenced a hold decision on Canadian cannabis firm CannTrust Holdings (TSX:TRST)(NYSE:CTST) when everyone else was bailing out of the…
Read MoreBet Against the Cannabis Industry With This ETF
Cannabis stocks have been dreadful over the past several months. Even top pot stock Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has fallen hard. From highs of more than $70 per share back in April, its share price has been cut by more than half since then. The turning point for the industry occurred in the summer when the CannTrust scandal emerged and Canopy’s co-CEO at…
Read MoreWhy Aurora Cannabis (TSX:ACB) Stock Fell 13.53% Last Friday
Aurora Cannabis (TSX:ACB)(NYSE:ACB) had an epic one-day loss last week, falling 13.53% from its Thursday closing price to its Friday closing price. The losses came after months of bad news for the cannabis industry, ranging from CannTrust’s Health Canada scandal to Canopy’s $1.23 billion loss. Aurora itself has not been the biggest disaster among cannabis companies; nevertheless, its stock has been among the biggest…
Read MoreCould CannTrust Shares Double in Value?
CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) has gone through a lot of turmoil since July when we first learned of the company’s illegal growing operations. Since then, shares have fallen by more than 75% in value. However, with such a massive drop in price, there’s definitely room for a big recovery for CannTrust – if it can get its cannabis licence reinstated, which would…
Read MoreLayoffs, Licences, and Losses: Inside CannTrust’s (TSX:TRST) Horrible Year
CannTrust Holdings (TSX:TRST)(NYSE:CTST) has been one of the worst-performing cannabis stocks of 2019. Down 78% year to date, it has dramatically underperformed the Horizons Medical Marijuana Index ETF, which tracks the cannabis sector has a whole. CannTrust’s 2019 slide has been driven by a series of unfortunate events, some of which call into question the company’s ability to keep selling cannabis.…
Read MoreCan CannTrust (TSX:TRST) Stock Double Your Money?
CannTrust Holdings (TSX:TRST)(NYSE:CTST) could be one big cannabis name that blemished the industry reputation much more than any other due to its size, popularity, and the nature of its premeditated regulations violation, but the stock is a potentially rewarding contrarian buy for traders today, as shares could double. As I argued in an opinion piece earlier, the stage has been…
Read More